First reimbursement category for health apps announced in Switzerland

On December 3, 2025, the Swiss Federal Office of Public Health announced the update of Annex 2 of the Health Care Benefit Ordinance (KLV/OPre), also known as the List of Medical Aids (MiGeL), which lists medical aids reimbursable by the Swiss compulsory health insurance. 

From July 1, 2026, the MiGeL List will include a new chapter 40 titled "Digital health applications (dGA) with medical purpose". These products are defined as software or apps (potentially utilizing AI or physical components) that utilize digitally documented data to perform medical evaluations and provide individualized recommendations.

Chapter 40 introduces a general limitation requiring that clinical evidence of efficacy and appropriateness is available for a specific dGA. Furthermore, the prescribed dGA must demonstrate treatment progress, a learning effect, and/or facilitate independent disease management.

The first product category introduced belongs to the Sub-chapter 40.01 "Mental and behavioral disorders". Starting July 1, 2026, it will include a generic category 40.01.01.00.1 for interactive dGA for Cognitive Behavioral Therapy (CBT) for depression, designed for sole self-application. The tariff of 171.32 CHF covers a 90-day license. The MiGeL List provides specifications regarding indications, prescribers, and usage context for this new reimbursement category.

This new reimbursement category is explicitly registered with the status "In evaluation until December 31, 2026", which means it falls under the Coverage with Evidence Development scheme (Leistungen in Evaluation).

See the details in German here.

This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.